1-2 of 2
Judit Varkonyi, MD, PhD
Close
Sort by
Journal Articles

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

Juan Sainz, PhD, Carmen Belén Lupiañez, Daniele Campa, PhD, Gabriele Buda, MD, Hernan Jose Moreno, MD, Marek Dudziński, PhD, Charles Dumontet, MD PhD, Ramón García-Sanz, MD PhD, Krzysztof Jamroziak, MD PhD, Artur J. Jurczyszyn, MD PhD, Stefano Landi, MD PhD, Fabienne Lesueur, PhD, Herlander Marques, MD PhD, Joaquín Martínez-López, MD PhD, Victor Moreno, MD PhD, Mario Petrini, MD PhD, Rui Manuel Reis, MD PhD, Zofia Szemraj-Rogucka, MD PhD, Annette Juul Vangsted, MD PhD, Judit Varkonyi, MD PhD, Ulla Vogel, MD PhD, Marzena Wątek, MD PhD, Federico Canzian, PhD, Rafael Rios, MD
Journal: Blood
Blood (2014) 124 (21): 2044.
https://doi.org/10.1182/blood.V124.21.2044.2044
Published: 2014
Journal Articles

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease.

Hajnalka Andrikovics, MD, PhD, Nora Meggyesi, Aniko Szilvasi, Julia Tamaska, MD, Gabriella Halm, MD, Sandor Lueff, MD, Sarolta Nahajevszky, MD, Miklos Egyed, MD, PhD, Judit Varkonyi, MD, PhD, Gabor Mikala, MD, PhD, Andrea Sipos, MD, Attila Tordai, MD, PhD, Tamas Masszi, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4904.
https://doi.org/10.1182/blood.V108.11.4904.4904
Published: 2006